NMS · Biotechnology

Rigel Pharmaceuticals, Inc. (RIGL) Stock

$45.97 -2.71% NMS: RIGL Healthcare

Valuation

MetricValue
Price$45.97
Market Cap$858.71M
P/E Ratio2.67
P/B Ratio2.05
P/S Ratio3.15
EPS (TTM)$19.48
52-Week High$52.24
52-Week Low$24.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE96.49%
ROA61.78%
ROCE20.45%
Gross Margin42.52%
Operating Margin42.52%
Net Margin116.30%
Debt/Equity0.09
Current Ratio2.42

Annual Financials (USD)

Metric20212022202320242025
Revenue$149.0M$120.0M$117.0M$179.0M$294.0M
Operating Profit$-12.0M$-56.0M$-20.0M$24.0M$125.0M
Net Profit$-18.0M$-59.0M$-25.0M$17.0M$367.0M
EPS$-1.10$-3.40$-1.44$0.99$19.48
Op Margin-8.4%-46.2%-17.5%13.5%42.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$167.0M$134.0M$117.0M$164.0M$514.0M
Total Liabilities$137.0M$148.0M$146.0M$161.0M$122.0M
Cash$19.0M$24.0M$33.0M$57.0M$41.0M
Borrowings$31.0M$42.0M$61.0M$60.0M$53.0M

Latest News

Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock? Zacks · Jul 7, 2026 Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire · Jul 7, 2026 Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer PR Newswire · Jul 1, 2026 Rigel Pharmaceuticals Closes Licensing Deal for Breast Cancer Drug Veppanu MT Newswires · Jun 16, 2026 Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant) PR Newswire · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$6.0M$-74.0M$-6.0M$31.0M$76.0M
Investing Cash Flow$-81.0M$72.0M$-19.0M$4.0M$-92.0M
Financing Cash Flow$63.0M$-13.0M$-2.0M$-12.0M$0
Net Cash Flow$-11.0M$6.0M$8.0M$24.0M$-16.0M
Free Cash Flow$5.0M$-74.0M$-21.0M$31.0M$76.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA9.06
FCF Yield9.10%
Quick Ratio1.79
Interest Coverage15.00
Return 1Y74.75%
Return 3Y189.92%
Return 5Y0.66%

Ownership

Insiders Held3.39%
Institutions Held94.11%
Institutions Float Held97.41%
Institutional HolderSharesReport Date
Blackrock Inc.1,768,9072026-03-31
Armistice Capital, LLC1,280,0002026-03-31
State Street Corporation1,120,2382026-03-31
Vanguard Capital Management LLC764,1932026-03-31
Acadian Asset Management. LLC666,4262026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALXOALX Oncology Holdings Inc. $1.06 +6.00% -1.08 $146.57M 0.00%
ANLAdlai Nortye Ltd. $13.26 +2.00% -8.19 $703.84M 0.00%
CCCCC4 Therapeutics, Inc. $2.77 -0.54% -2.95 $340.16M 0.00%
CGEMCullinan Therapeutics, Inc. $12.93 -7.64% -4.60 $794.65M 0.00%
CRDFCardiff Oncology, Inc. $0.90 -7.20% -1.87 $70.10M 0.00%

About Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. is led by CEO Raul R. Rodriguez, employs 162 people, headquartered in US, publicly traded since 2000.

Rigel Pharmaceuticals, Inc. (RIGL) stock trades at $45.97 with a market capitalization of $858.71M. The stock is valued at a price-to-earnings (P/E) ratio of 2.67, price-to-book of 2.05, price-to-sales of 3.15. Over the past 52 weeks the stock has ranged between $24.95 and $52.24, and currently trades 12.0% below its 52-week high.

On profitability, Rigel Pharmaceuticals, Inc. generates a return on equity (ROE) of 96.49%, above the typical market range of roughly 12-15%, return on capital employed of 20.45%, an operating margin of 42.52%, a net profit margin of 116.30%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1257.03 +0.43% JNJ Johnson & Johnson $255.56 +0.90% ABBV AbbVie Inc. $285.42 +0.71% UNH UnitedHealth Group Incorporated Common Stock (DE) $401.43 -1.29% MRK Merck & Company, Inc. Common Stock (new) $145.97 +0.53% NVS Novartis AG $150.62 +0.16% AZN AstraZeneca PLC $165.41 -0.76% TMO Thermo Fisher Scientific Inc $690.00 -0.93% AMGN Amgen Inc. $432.49 -0.35% GILD Gilead Sciences, Inc. $156.19 -0.75% ABT Abbott Laboratories $104.88 +0.19% NVO Novo Nordisk A/S $38.83 -0.99%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.